SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-035594
Filing Date
2024-03-18
Accepted
2024-03-18 16:37:45
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tm249084d1_424b5.htm 424B5 564432
2 GRAPHIC image_002.jpg GRAPHIC 2483
3 GRAPHIC tm242191d1_424b5img002.jpg GRAPHIC 31147
4 GRAPHIC tm242191d1_424b5img003.jpg GRAPHIC 69304
5 GRAPHIC image_001.jpg GRAPHIC 2252
  Complete submission text file 0001104659-24-035594.txt   711239
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255318 | Film No.: 24759608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)